Reducing DMARDs in patients in stable remission is feasible with close monitoring, a trial shows, but an Australian expert says several questions need to be addressed before tapering or dose-reduction strategies become routine in clinical practice. The Rheumatoid Arthritis in Ongoing Remission (RETRO) study assessed the effect of tapering and stopping treatment with DMARDs in ...
Tapering DMARDs in stable patients is feasible – but is it practical?
By Selina Wellbelove
7 Oct 2021